Metraipolis › archive › dc_fa17b6942f25

Targeting CREB3L2-mediated lipid metabolism overcomes lenvatinib resistance and attenuates the progression of hepatocellular carcinoma — Europe PMC PMID:41285809

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41285809
DOI
10.1038/s41419-[numero omesso]-3
License (as archived)
solo-consultazione
Archived
2026-11-08T07:23:37.667Z
SHA-256 of the archived text
03be48edd701fd6e5581e455a9672d4c0583ff8f8dc794847d89e596882e0fc4
Stable URL of this page
https://metraipolis.com/documento/dc_fa17b6942f25

How to cite

Targeting CREB3L2-mediated lipid metabolism overcomes lenvatinib resistance and attenuates the progression of hepatocellular carcinoma — Europe PMC PMID:41285809 — Europe PMC (en), https://europepmc.org/article/MED/41285809 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fa17b6942f25 (Metraipolis archive dc_fa17b6942f25, sha256 03be48edd701fd6e5581e455a9672d4c0583ff8f8dc794847d89e596882e0fc4)
BibTeX
@misc{dcfa17b6942f25,
  title = {Targeting CREB3L2-mediated lipid metabolism overcomes lenvatinib resistance and attenuates the progression of hepatocellular carcinoma — Europe PMC PMID:41285809},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41285809},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fa17b6942f25; sha256 03be48edd701fd6e5581e455a9672d4c0583ff8f8dc794847d89e596882e0fc4},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41285809. Agents can read the archived copy with the MCP tool read_document.